• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Novel daidzein analogs and their in vitro anti-influenza activities

tetano

Editor, Senior Moderator
Chem Biodivers. 2015 Apr;12(4):685-96. doi: 10.1002/cbdv.201400337.
[h=1]Novel daidzein analogs and their in vitro anti-influenza activities.[/h] Chung ST[SUP]1[/SUP], Huang YT, Hsiung HY, Huang WH, Yao CW, Lee AR.
[h=3]Author information[/h]

[h=3]Abstract[/h] A series of novel isoflavonoids were synthesized based on structural modifications of daidzein, an active ingredient of traditional Chinese medicine (TCM) and evaluated for their anti-influenza activity, in vitro, against H1N1 Tamiflu-resistant (H1N1 TR) virus in the MDCK cell line. Among them, 4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g were most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent. 3-(4-Bromophenyl)-7-hydroxy-4-oxo-4H-1-benzopyran-8-carboxaldehyde (11c) displayed the best inhibitory activity (EC50 , 29.0 μM) and selectivity index (SI>10.3). Analysis of the structureactivity relationships (SAR) indicated that both the non-naturally-occurring Br-substituted B-ring and appropriate CHO and OH groups on the A-ring might be critical for the activity and selectivity against H1N1 TR influenza viruses.
Copyright ? 2015 Verlag Helvetica Chimica Acta AG, Z?rich.


[h=4]KEYWORDS:[/h] Anti-influenza virus; Daidzein; H1N1 Tamiflu-resistant virus; Isoflavonoids

PMID: 25879510 [PubMed - in process]
 
Back
Top Bottom